Dopamine synthesis in the nigrostriatal system at the presymptomatic and early symptomatic stages in parkinsonian mice.
G R Khakimova, E A Kozina, A Ya Sapronova, M V Ugrumov
Author Information
- G R Khakimova: Kol'tsov Institute of Developmental Biology, Russian Academy of Sciences, Moscow, Russia.
No abstract text available.
- J Neural Transm. 1973;34(2):79-91
[PMID: 4146642]
- Zh Nevrol Psikhiatr Im S S Korsakova. 2010;110(7):41-7
[PMID: 20639856]
- Brain Struct Funct. 2009 Feb;213(3):289-300
[PMID: 18841392]
- J Nucl Med. 1995 Jul;36(7):1226-31
[PMID: 7790948]
- J Neural Transm Gen Sect. 1990;80(1):9-31
[PMID: 2407269]
- Nature. 1985 Feb 21-27;313(6004):679-82
[PMID: 3974701]
- J Pharmacol Exp Ther. 1965 Apr;148:1-8
[PMID: 14279179]
- Neurobiol Dis. 1997;4(3-4):247-53
[PMID: 9361301]
- J Pharmacol Exp Ther. 1975 Dec;195(3):453-64
[PMID: 489]
- Neurology. 1982 May;32(5):514-39
[PMID: 7200209]
- Psychopharmacologia. 1973;29(4):289-98
[PMID: 4707021]
- Ann Neurol. 1988 Oct;24(4):574-6
[PMID: 3239957]
- Pharmacol Rev. 1966 Jun;18(2):925-64
[PMID: 5328389]
- Ross Fiziol Zh Im I M Sechenova. 2010 Mar;96(3):270-82
[PMID: 20535997]
Animals
Antiparkinson Agents
Corpus Striatum
Dopamine
Dopamine Agents
Levodopa
Male
Mice
Mice, Inbred C57BL
Parkinsonian Disorders
Substantia Nigra
Tyrosine 3-Monooxygenase
Antiparkinson Agents
Dopamine Agents
Levodopa
Tyrosine 3-Monooxygenase
Dopamine
